NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 82 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $768 | +18.5% | 925 | 0.0% | 0.00% | – |
| Q1 2023 | $648 | +37.6% | 925 | 0.0% | 0.00% | – |
| Q4 2022 | $471 | -52.9% | 925 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | 0.0% | 925 | -29.7% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | -83.3% | 1,316 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $6,000 | -40.0% | 1,316 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $10,000 | -16.7% | 1,316 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $12,000 | -25.0% | 1,316 | 0.0% | 0.01% | -22.2% |
| Q1 2021 | $16,000 | -11.1% | 1,316 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $18,000 | -14.3% | 1,316 | 0.0% | 0.01% | -42.9% |
| Q2 2020 | $21,000 | +250.0% | 1,316 | -41.7% | 0.02% | +425.0% |
| Q3 2019 | $6,000 | – | 2,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,291,133 | $1,166,187 | 1.01% |
| Privium Fund Management (UK) Ltd | 117,200 | $59,655 | 0.04% |
| Redmile Group, LLC | 1,850,566 | $941,938 | 0.04% |
| Baker Brothers Advisors | 3,821,740 | $1,945,266 | 0.01% |
| Kynam Capital Management, LP | 120,764 | $61,469 | 0.01% |
| Sio Capital Management, LLC | 38,312 | $19,501 | 0.01% |
| SIMON QUICK ADVISORS, LLC | 46,856 | $23,850 | 0.00% |
| Tri Locum Partners LP | 10,248 | $5,000 | 0.00% |
| Endurance Wealth Management, Inc. | 20,000 | $10 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $38,175 | 0.00% |